JP4231559B2
(ja)
|
1997-04-23 |
2009-03-04 |
オリザ油化株式会社 |
リポキシゲナーゼ阻害剤
|
AU763839B2
(en)
|
1998-05-26 |
2003-07-31 |
Warner-Lambert Company |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
CN1150195C
(zh)
|
1998-10-23 |
2004-05-19 |
霍夫曼-拉罗奇有限公司 |
双环氮杂环
|
AU2003225161A1
(en)
|
2002-04-24 |
2003-11-10 |
Koo, Han-Mo |
Enhancement of human epidermal melanogenesis
|
US7084270B2
(en)
|
2002-08-14 |
2006-08-01 |
Hoffman-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
US20060094013A1
(en)
|
2002-08-21 |
2006-05-04 |
Hiroshi Takemori |
Salt-inducible kinases 2 and use thereof
|
US7129351B2
(en)
*
|
2002-11-04 |
2006-10-31 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
JP2006508997A
(ja)
|
2002-11-28 |
2006-03-16 |
シエーリング アクチエンゲゼルシャフト |
Chk−、Pdk−およびAkt−阻害性ピリミジン、それらの製造および薬剤としての使用
|
CN100497339C
(zh)
*
|
2003-04-10 |
2009-06-10 |
霍夫曼-拉罗奇有限公司 |
嘧啶并化合物
|
US7504396B2
(en)
|
2003-06-24 |
2009-03-17 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
EP1651648A4
(en)
|
2003-07-29 |
2009-09-02 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
ES2396135T3
(es)
|
2004-06-10 |
2013-02-19 |
Irm Llc |
Compuestos y composiciones como inhibidores de proteínas cinasas
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
US7655651B2
(en)
|
2004-08-31 |
2010-02-02 |
Hoffmann-La Roche Inc. |
Amide derivatives of 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
|
WO2006024545A1
(en)
|
2004-09-03 |
2006-03-09 |
Stichting Voor De Technische Wetenschappen |
Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes
|
AU2005322855B2
(en)
|
2004-12-30 |
2012-09-20 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
KR20080002865A
(ko)
|
2005-03-25 |
2008-01-04 |
글락소 그룹 리미티드 |
피리도[2,3-d]피리미딘-7-온 및3,4-디히드로피리미도[4,5-d]피리미딘-2(1h)-온유도체의 제조 방법
|
CA2610598A1
(en)
*
|
2005-06-10 |
2006-12-21 |
Irm Llc |
Compounds that maintain pluripotency of embryonic stem cells
|
WO2007071752A2
(en)
|
2005-12-21 |
2007-06-28 |
Novartis Ag |
Pyrimidinyl aryl urea derivatives being fgf inhibitors
|
JP2009537520A
(ja)
*
|
2006-05-15 |
2009-10-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Fgf受容体キナーゼ阻害剤のための組成物および方法
|
WO2008060248A1
(en)
|
2006-11-15 |
2008-05-22 |
S*Bio Pte Ltd. |
Indole sustituted pyrimidines and use thereof in the treatment of cancer
|
EA019869B1
(ru)
|
2007-11-28 |
2014-06-30 |
Дана Фарбер Кансер Инститьют, Инк. |
Низкомолекулярные миристатные ингибиторы тирозинкиназы bcr-abl и способы их применения
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
WO2009152027A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one derivatives for mark inhibition
|
JP2011530511A
(ja)
|
2008-08-05 |
2011-12-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
治療用化合物
|
CA2745959A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Msd K.K. |
Dihydropyrimidopyrimidine derivatives
|
EP2488526B1
(en)
|
2009-10-14 |
2013-07-24 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
CN102816162B
(zh)
*
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
CN103930427B
(zh)
|
2011-09-30 |
2016-03-09 |
昂科迪塞恩股份有限公司 |
大环flt3激酶抑制剂
|
AU2012340200B2
(en)
|
2011-11-17 |
2017-10-12 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-Terminal Kinase (JNK)
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
PT2841428T
(pt)
|
2012-04-24 |
2018-11-29 |
Vertex Pharma |
Inibidores de adn-pk
|
GB201212960D0
(en)
*
|
2012-07-20 |
2012-09-05 |
Common Services Agency |
Erythroid production
|
JP5683634B2
(ja)
*
|
2012-11-28 |
2015-03-11 |
株式会社ショーワ |
圧力緩衝装置
|
US9260426B2
(en)
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
WO2014138485A1
(en)
*
|
2013-03-08 |
2014-09-12 |
Irm Llc |
Ex vivo production of platelets from hematopoietic stem cells and the product thereof
|
AU2014230125A1
(en)
|
2013-03-15 |
2015-10-29 |
Oncodesign S.A. |
Macrocyclic salt-inducible kinase inhibitors
|
AU2014228746B2
(en)
*
|
2013-03-15 |
2018-08-30 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
CN104418860B
(zh)
*
|
2013-08-20 |
2016-09-07 |
中国科学院广州生物医药与健康研究院 |
嘧啶并杂环类化合物及其药用组合物和应用
|
DK3172213T3
(da)
|
2014-07-21 |
2021-12-13 |
Dana Farber Cancer Inst Inc |
Makrocykliske kinasehæmmere og anvendelser deraf
|
EP3171874B1
(en)
|
2014-07-21 |
2020-11-18 |
Dana-Farber Cancer Institute, Inc. |
Imidazolyl kinase inhibitors and uses thereof
|
EP3536323A1
(en)
|
2014-08-08 |
2019-09-11 |
Dana Farber Cancer Institute, Inc. |
Uses of salt-inducible kinase (sik) inhibitors
|
KR101850282B1
(ko)
|
2014-11-26 |
2018-05-31 |
한국과학기술연구원 |
단백질 키나아제 저해제로 유용한 헤테로아릴아민 유도체
|
CN104482860B
(zh)
|
2014-12-05 |
2017-10-31 |
浙江大学宁波理工学院 |
鱼类形态参数自动测量装置和方法
|
CN110225914A
(zh)
|
2016-07-05 |
2019-09-10 |
布罗德研究所股份有限公司 |
双环脲激酶抑制剂及其用途
|
WO2018053373A1
(en)
*
|
2016-09-16 |
2018-03-22 |
The General Hospital Corporation |
Uses of satl-inducible kinase (sik) inhibitors for treating osteoporosis
|
JP7296318B2
(ja)
|
2017-02-28 |
2023-06-22 |
ザ ジェネラル ホスピタル コーポレイション |
Sikインヒビターとしてのピリミドピリミジノンの使用
|